RCKT - Rocket Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RCKT is currently covered by 8 analysts with an average price target of $7.71. This is a potential upside of $12.5 (89.43%) from yesterday's end of day stock price of $4.07.

Rocket Pharmaceuticals's activity chart (see below) currently has 110 price targets and 119 ratings on display. The stock rating distribution of RCKT is 23.53% HOLD, 70.59% BUY and 5.88% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.21% with an average time for these price targets to be met of 122.53 days.

Highest price target for RCKT is $11, Lowest price target is $3, average price target is $7.71.

Most recent stock forecast was given by from CHARDAN CAPITAL on 11-May-2026. First documented stock forecast 28-Jul-2015.

Currently out of the existing stock ratings of RCKT, 4 are a HOLD (23.53%), 12 are a BUY (70.59%), 1 are a SELL (5.88%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Nov-2019

$11

$7.75 (238.46%)

$11

1 months 27 days ago
(11-May-2026)

3/15 (20%)

$7.41 (206.41%)

142

Buy Since 18-Nov-2025

$9

$5.75 (176.92%)

$8

3 months 8 days ago
(30-Mar-2026)

0/3 (0%)

$5.55 (160.87%)

Sell Since 02-Mar-2026

$3

$-0.25 (-7.69%)

$13

4 months 6 days ago
(02-Mar-2026)

1/5 (20%)

$-1.97 (-39.64%)

78

Buy Since 28-Jul-2015

$10

$6.75 (207.69%)

$8

4 months 11 days ago
(27-Feb-2026)

0/9 (0%)

$4.99 (99.60%)

Hold Since 06-Oct-2025

$7

$3.75 (115.38%)

$9

9 months 2 days ago
(06-Oct-2025)

1/13 (7.69%)

$3.82 (120.13%)

374

Show more analysts

Please expand the browser size to see the chart

What is RCKT (Rocket Pharmaceuticals) average time for price targets to be met?

On average it took 122.53 days on average for the stock forecasts to be realized with a an average price target met ratio 33.21

Which analyst has the current highest performing score on RCKT (Rocket Pharmaceuticals) with a proven track record?

ESTHER RAJAVELU

Which analyst has the most public recommendations on RCKT (Rocket Pharmaceuticals)?

Esther Rajavelu has 5 price targets and 6 ratings on RCKT

Which analyst is the currently most bullish on RCKT (Rocket Pharmaceuticals)?

Corey Davis with highest potential upside - $83.86

Which analyst is the currently most reserved on RCKT (Rocket Pharmaceuticals)?

Andrew Tsai with lowest potential downside - -$1.34

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?